| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 03/02/1999 | US5877190 Substituted biphenyl compounds |
| 03/02/1999 | US5877188 Psychological and behavioral disorders, antiemetics |
| 03/02/1999 | US5877175 3-(pyrimidin-4-yl)-1-phenylpyridazin-4(1h)-ones, treatment of seizures and/or neurological disorders such as epilepsy and/or conditions in which there is neurological damage such as brain trauma, cerebral ischaemia, hemorrhage, head injuries and |
| 03/02/1999 | US5877172 Process for isolating galanthamine |
| 03/02/1999 | US5877016 Human trk receptors and neurotrophic factor inhibitors |
| 03/02/1999 | US5877015 APP770 mutant in alzheimer's disease |
| 03/02/1999 | US5876973 Method for making antibodies which specifically bind to glial growth factors |
| 03/02/1999 | US5876972 Nucleic acid molecules coding for tumor suppressor proteins and methods for their isolation |
| 03/02/1999 | US5876948 Screening methods to identify neurotoxin inhibitors |
| 03/02/1999 | US5876751 Antispasmodic and antinflammatory composition and a process for the manufacture thereof |
| 03/02/1999 | US5876737 Use of salicin as an anti-irritative active compound in cosmetic and topical dermatological preparations |
| 03/02/1999 | US5876727 Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same |
| 03/02/1999 | US5876693 Hydroxyalkyl phosphine compounds for use as diagnostic and therapeutic pharmaceuticals |
| 03/02/1999 | CA2241417A1 Novel ffh |
| 03/02/1999 | CA2175352C 3-aryl-4-alkyl and 4,5-dialkyl-4h-1,2,4-triazoles useful as memory enhancers |
| 02/28/1999 | CA2241427A1 Novel pyrr homolog |
| 02/28/1999 | CA2241400A1 Ftsy |
| 02/26/1999 | CA2241431A1 Novel spoiiie |
| 02/25/1999 | WO1999009171A1 Ubc7-like ubiquitin-conjugating enzyme |
| 02/25/1999 | WO1999009147A1 Truncated platelet-activating factor acetylhydrolase |
| 02/25/1999 | WO1999009140A1 Nucleic acid sequences encoding capsaicin receptor and capsaicin receptor-related polypeptides and uses thereof |
| 02/25/1999 | WO1999009061A1 Secreted proteins |
| 02/25/1999 | WO1999009054A2 Peroxisome-associated polypeptide, nucleotide sequence encoding said polypeptide and their uses in the diagnosis and/or the treatment of lung injuries and diseases, and of oxidative stress-related disorders |
| 02/25/1999 | WO1999009025A2 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-1h-indole derivatives interacting with the dopamine d4 receptor |
| 02/25/1999 | WO1999009024A1 Phenyl urea and phenyl thiourea derivatives as hfgan72 antagonists |
| 02/25/1999 | WO1999009022A1 Furansulfonic acid derivatives and pharmaceutical compositions containing the same |
| 02/25/1999 | WO1999009015A1 2-{3-[4-(2-t-butyl-6- trifluoromethylpyridin-4-yl) piperazin-1-yl] propylmercapto} pyrimidin-4-ol-fumarate |
| 02/25/1999 | WO1999009010A1 Crystalline 10,10-bis((2-fluoro-4-pyridinyl)methyl)-9(10h)-anthracenone and an improved process for preparing the same |
| 02/25/1999 | WO1999008987A1 Cyclohexenone long-chain alcohol and medicament containing same |
| 02/25/1999 | WO1999008702A1 Methods for treatment of patients afflicted wih multiple sclerosis using consensus interferon |
| 02/25/1999 | WO1999008685A1 Phosphono-carboxylate compounds for treating amyloidosis |
| 02/25/1999 | WO1999008682A1 A method of preventing or treating estrogen-dependent diseases and disorders |
| 02/25/1999 | WO1999008678A1 Heterocyclic vinylethers against neurological disorders |
| 02/25/1999 | WO1999008671A1 Gaba analogs to prevent and treat gastrointestinal damage |
| 02/25/1999 | WO1999008670A1 Gaba analogs to prevent and treat gastrointestinal damage |
| 02/25/1999 | WO1999008533A1 Central nervous system axon regeneration |
| 02/25/1999 | WO1999008524A1 Methods for preventing headaches |
| 02/25/1999 | WO1999008521A1 Treatment or prophylaxis of retinal pathology and spinal cord injury |
| 02/25/1999 | WO1999008519A1 Polyamine treatment of neurological disorders |
| 02/25/1999 | WO1998053050A3 Short peptides which selectively modulate the activity of serine/threonine kinases |
| 02/25/1999 | CA2301297A1 2-{3-[4-(2-t-butyl-6- trifluoromethylpyridin-4-yl) piperazin-1-yl] propylmercapto} pyrimidin-4-ol-fumarate |
| 02/25/1999 | CA2301074A1 Crystalline 10,10-bis((2-fluoro-4-pyridinyl)methyl)-9(10h)-anthracenone and an improved process for preparing the same |
| 02/25/1999 | CA2300918A1 Ubc7-like ubiquitin-conjugating enzyme |
| 02/25/1999 | CA2300878A1 Central nervous system axon regeneration |
| 02/25/1999 | CA2300821A1 Methods for preventing headaches |
| 02/25/1999 | CA2300694A1 Furansulfonic acid derivatives and pharmaceutical compositions containing the same |
| 02/25/1999 | CA2300178A1 Phenyl urea and phenyl thiourea derivatives as hfgan72 antagonists |
| 02/25/1999 | CA2300135A1 Treatment or prophylaxis of retinal pathology and spinal cord injury |
| 02/25/1999 | CA2298866A1 Peroxisome-associated polypeptide, nucleotide sequence encoding said polypeptide and their uses in the diagnosis and/or the treatment of lung injuries and diseases, and of oxidative stress-related disorders |
| 02/25/1999 | CA2298540A1 Nucleic acid sequences encoding capsaicin receptor and capsaicin receptor-related polypeptides and uses thereof |
| 02/25/1999 | CA2241403A1 Murb |
| 02/25/1999 | CA2241392A1 Pigr-2, a member of immunoglobulin gene superfamily |
| 02/25/1999 | CA2239260A1 Human disintegrin metalloprotease related to drosophila kuz gene |
| 02/24/1999 | EP0897980A2 CXCR4B: A human splice variant of CXCR4 chemokine receptor |
| 02/24/1999 | EP0897979A2 Human sdr2 cdna clone |
| 02/24/1999 | EP0897921A1 Benzothiadiazinyl-indole derivatives and their use as serotonin receptor ligands |
| 02/24/1999 | EP0897723A1 Benzo(b)thiophene derivatives for preventing headaches |
| 02/24/1999 | EP0673375B1 Fused benzo compounds |
| 02/24/1999 | CN1209126A Novel compounds with analgesic effect |
| 02/24/1999 | CN1209125A Piperazine derivatives as tachykinin antagonists |
| 02/24/1999 | CN1209124A Novel compounds with analgesic effect |
| 02/24/1999 | CN1208651A Medicine for treating epilepsy |
| 02/24/1999 | CN1208649A Medicated wine for treating pain in waist and lower extremities and rheumatic arthritis |
| 02/24/1999 | CN1208633A Application of theaflavine for prepn. of medicine for treating cerebral senilism and dementia |
| 02/24/1999 | CN1042225C Substituted isoxazole derivatives prepn. method |
| 02/23/1999 | US5874583 Treating depression, obsessive compulsive disorder, stuttering, trichotillomania |
| 02/23/1999 | US5874531 Polypeptides implicated as self epitope in autoimmune disease pemphigus vulgaris and multiple scelerosis |
| 02/23/1999 | US5874462 Use of substituted 6-amino-4H-pyrans |
| 02/23/1999 | US5874458 Psychological disorders |
| 02/23/1999 | US5874457 Imidazolylalkyl derivatives of imidazo 1,5-a!indol-3-one |
| 02/23/1999 | US5874450 Aqueous buffered solution having alkaline ph containing a sleep promoting amount of doxylamine and anionic surfactants selected from long chain hydrocarbon sulfonates or carboxylates |
| 02/23/1999 | US5874447 High purity organosulfonate salt of paroxetine with excellent stability, solubility; react with a base to make high purity paroxetine, or with a reagent to make the high purity salt of said reagent (ex: paroxetine maleate from maleic acid) |
| 02/23/1999 | US5874445 (+) -α- (2,3-dimethoxyphenyl)-1-(2-(4-fluorephenyl) ethyl)-4-piepridinemethanol |
| 02/23/1999 | US5874435 Psychological disorders; analgesics |
| 02/23/1999 | US5874428 N-substituted aza-heterocyclic carboxylic acids and esters thereof |
| 02/23/1999 | US5874427 Substituted heteroaromatic 5-HT1F agonists |
| 02/23/1999 | US5874426 Cyclic amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists |
| 02/23/1999 | US5874420 Process for regulating vagal tone |
| 02/23/1999 | US5874273 Nucleic acids for encoding genes and amino acid sequences and hybridization and nucleotide sequences |
| 02/23/1999 | US5874252 Splicing variant of the Epstein-Barr virus-induced G-protein coupled receptor |
| 02/23/1999 | US5874245 Human G-protein coupled receptor (HIBCD07) |
| 02/23/1999 | US5874243 OLRCC15 receptor |
| 02/23/1999 | US5874227 Binds to corticotropin factor; competitive binding assay for screening ligands |
| 02/23/1999 | US5874224 Growth factor receptor binding protein |
| 02/23/1999 | US5874090 Sustained-release formulation of methylphenidate |
| 02/23/1999 | CA2146007C Substituted quinuclidines |
| 02/22/1999 | CA2245331A1 Pharmaceutical compounds |
| 02/20/1999 | CA2241429A1 Cxcr4b: a human splice variant of cxcr4 chemokine receptor |
| 02/18/1999 | WO1999007843A1 Human glial cell line-derived neurotrophic factor promoters, vectors containing same, and methods of screening compounds therewith |
| 02/18/1999 | WO1999007741A1 Meningococcus vaccine comprising the valence of bz83 strain |
| 02/18/1999 | WO1999007729A2 Peptides having potassium channel opener activity |
| 02/18/1999 | WO1999007711A1 3-substituted 3,4,5,7-tetrahydro-pyrrolo3',4':4,5 thieno2,3-dpyrimidine derivatives, their preparation and use as 5ht antagonists |
| 02/18/1999 | WO1999007708A1 1,3-dioxolo/4,5-h//2,3/benzodiazepine derivatives as ampa/kainate receptor inhibitors |
| 02/18/1999 | WO1999007707A1 8-SUBSTITUTED-9H-1,3-DIOXOLO/4,5-h//2,3/BENZODIAZEPINE DERIVATIVES, AS AMPA/KAINATE RECEPTOR INHIBITORS |
| 02/18/1999 | WO1999007705A1 Purine inhibitor of protein kinases, g proteins and polymerases |
| 02/18/1999 | WO1999007703A1 4-AMINOPYRROLE(3,2-d) PYRIMIDINES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS |
| 02/18/1999 | WO1999007700A1 Bicyclic compounds as ligands for 5-ht1 receptors |
| 02/18/1999 | WO1999007681A1 2-acylaminopropanamines as tachykinin receptor antagonists |
| 02/18/1999 | WO1999007669A1 Anthranilic acid analogs |
| 02/18/1999 | WO1999007406A1 C1q AND COLLECTIN RECEPTOR |